Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

31/03/2015
As first EU Ministerial meeting on tuberculosis closes, MSF calls on the EU to triple funding for TB R&D

As the first-ever Eastern Partnership Ministerial Conference on Tuberculosis and Multidrug-Resistant Tuberculosis concludes in Riga, Latvia today , Médecins Sans Frontières (MSF) calls on the European Union to take concrete actions to boost the regional fight against TB, including tripling European funding for research and development (R&D). With drug-resistant TB...

Read more...





31/03/2015
TB Europe Coalition: Europe’s leaders approve Riga Declaration on TB and MDR-TB

Riga, 31st March 2015 – At the conclusion of the first Eastern Partnership Ministerial Conference on Tuberculosis  (TB) and Its Multidrug-Resistance (MDR-TB), the Tuberculosis Europe Coalition (TBEC) applauds the approval of the Riga Declaration by Ministers of Health, Finance and Social Affairs from across European Union Member States and Eastern Partnership countries....

Read more...





31/03/2015
ViiV Healthcare launches new global Positive Action programme focused on MSM and transgender populations

London, United Kingdom – 31 March, 2015 – ViiV Healthcare today announced the launch of a new initiative designed to support and inform the global effort to alleviate the impact of HIV and AIDS among men who have sex with men (MSM) and transgender populations around the world. Through Positive Action, ViiV Healthcare has committed to invest £2 million per year to...

Read more...

Source Source: ViiV Healthcare





31/03/2015
HCV sexual transmission linked to anal sex, drug use, lower CD4 count

In addition to the usual risk factors for hepatitis C virus (HCV) sexual transmission seen in most previous studies – such as anal sex and having other sexually transmitted infections – researchers in the Netherlands also saw an association with nasal and injection drug use and lower CD4 cell count, they reported in a poster presentation at the recent  Conference...

Read more...

Source Source: Aidsmap





31/03/2015
Duke researchers develop new model to study why some HPV infections go away and others progress

For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed. A new study finds that the body's ability to defeat the virus may be largely due to unpredictable division patterns in HPV-infected stem cells, rather than the...

Read more...

Source Source: The Medical News

Tags: HPV